Abbott's Libre Assist will help individuals with diabetes better understand how their food choices may affect their glucose ...

The XGBoost model predicts hyperglycemia risk in psoriasis patients with high accuracy, achieving an AUC of 0.821 in the training set. A web-based calculator was developed to facilitate personalized ...

Abbott (NYSE:ABT) today unveiled a new feature within its FreeStyle Libre app for continuous glucose monitoring (CGM).

Abbott has launched Libre Assist, a feature within the Libre app designed to help people living with diabetes better understand how the foods they eat affect their glucose levels.

AI and digital health devices should not be viewed as replacements for health care professionals, but as tools that can be ...

Libre Assist 1 uses generative AI to predict how a food choice may affect a person's glucose levels. 2 It then offers ...

Clinical trials underrepresent women, children, and adults aged 65 years or older, so diabetes guidelines must be adapted to ...

In 2025, that meant it was impossible for me to scroll through my feed without being visually assaulted by ingratiating ...

A conserved signaling axis linking Drosophila adipose tissue to nephrocyte function reveals how obesity can drive kidney dysfunction and points to new opportunities for therapeutic intervention.

Diabeloop announced today that its DBLG2 algorithm for automated insulin delivery has received FDA 510(k) clearance.